Wednesday, 22 May 2019

You are here

CDC Shows a 40% Lifetime Risk of Symptomatic Hand Osteoarthritis

Qin and colleagues have published in Arthritis & Rheumatology that 40% of people will be affected by symptomatic osteoarthritis in at least one hand.  (Citation source: http://buff.ly/2qTUscZ)  

They analyzed 2,218 adults ≥ 45 years from the Johnston County (NC) Osteoarthritis Project, specifically collecting looking for symptomatic hand OA (SHOA) over two time frames (1999-2004 and 2005-2010). SHOA was defined as having both self-reported symptoms and radiographic OA in the same hand.

The found the lifetime risk of SHOA is 39.8% with greater frequency in women as they age.  Women by age 85 yrs had a 47.2% frequency of SHOA compared to only 24.6% in men.

Hand OA was more common in whites moreso than blacks (41.4% vs 29.2%, respectively). The lifetime risk in the obese was 47.1 percent, compared to 36.1 percent for non-obese people.

Hand OA represents a significant publich health problem for which there are few, if any, credible treatment options.  Dr. Marc Hochberg and coworkers at OARSI have submitted a 103 page "white paper" to  FDA to designate OA as a "Serious Disease", staging that OA is a "serious disease for which there are no current satisfactory treatments". (Citation source: http://buff.ly/2pTuVm1)

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

CDC: One in Four US Adults have Arthritis

MMWR reports that in 2017, one in four US adults have arthritis (range from 22.8% to 34.6%), with higher rates in Appalachia and Lower Mississippi Valley regions. Of those with arthritis, 31% reported to have "severe arthritis".

More Studies Needed to Optimize the Use of Osteoporosis Drugs

The Annals of Internal Medicine reports a metanalysis done to examine the optimal length of long-term osteoporosis drug treatment (ODT) and whether harms are associated with long-term ODT and while the ODT benefits are clear, the risk of rare harms and need for drug holidays is less certain. 

NIH Workshop on Unmet Needs in Osteoporosis

In October 2018, the National Institutes of Health (NIH) convened a workshop to address the "Appropriate Use of Drug Therapies for Osteoporotic Fracture Prevention"

Intraarticular Trans-Capsaicin Effective in Knee OA

A novel study has shown that intraarticular therapy with high‐purity synthetic trans‐capsaicin (CNTX‐4975) for chronic knee osteoarthritis (KOA) was associated with significant relief of knee pain.

Smoking Not Protective Against Knee OA

Researchers found no protective effect of smoking against knee osteoarthritis (OA), according to a new longitudinal cohort study of 620 individuals with meniscal tears treated at five sites in Denmark. An inverse association between OA and smoking had been suggested by several previous studies and a recent meta-analysis.